Blood coagulation function detection system and method and storage medium

Through the coagulation function detection system integrating microfluidic module, multimodal data detection module and data processing module, the problem of insufficient sensitivity and accuracy of coagulation function detection in the prior art is solved, and the rapid and accurate evaluation of coagulation function is achieved. Meet the testing needs of different medical scenarios, reduce costs and improve user experience.

CN119044512APending Publication Date: 2024-11-29FULING HOSPITAL AFFILIATED TO CHONGQING UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411201368.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing coagulation function detection system is insufficient in terms of sensitivity and accuracy, cannot fully reflect the patient's coagulation status, and lacks intelligent data processing and analysis functions, cannot connect with the existing medical system, has high manufacturing cost, low production efficiency, and is limited Its application in POCT and Bedside Testing.

Method used

A blood coagulation function detection system with integrated communication connection is designed, including a microfluidic module, a multimodal data detection module and a data processing module. The microfluidic module is used to control the flow of blood samples and the coagulation cascade reaction, and multimodal The data detection module monitors the changes in fibrinogen concentration and prothrombin activity through optical and electrochemical detection. The data processing module inputs these signals into the coagulation function detection model to achieve rapid and accurate evaluation of coagulation function.

Benefits of technology

It realizes rapid, accurate and comprehensive evaluation of coagulation function, meets the immediate testing needs in different medical scenarios, improves the reliability and accuracy of testing, reduces detection costs, enhances user experience, and promotes data sharing and integration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119044512A_ABST
    Figure CN119044512A_ABST
Patent Text Reader

Abstract

The invention provides a blood coagulation function detection system and method and a storage medium, and the system comprises a microfluidic module, a multi-modal data detection module and a data processing module which are in communication connection; the micro-fluidic module is used for controlling the flow of the blood sample and the blood coagulation cascade reaction and simulating the blood coagulation process; the multi-modal data detection module comprises an optical detection sub-module and an electrochemical detection sub-module which are respectively used for monitoring fibrinogen concentration change signals and prothrombin activity change signals in the blood coagulation process; the data processing module is used for inputting the fibrinogen concentration change signal and the prothrombin activity change signal into a blood coagulation function detection model to obtain blood coagulation function states, and the blood coagulation function states comprise normal, hyperfunction and obstacle. By integrating the microfluidic module, the multi-modal data detection module and the data processing module, the intelligent panoramic instant analysis system of the blood coagulation function is formed, and rapid, accurate and comprehensive evaluation of the blood coagulation function is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of blood coagulation function detection, and in particular to a blood coagulation function detection system, method and storage medium. Background Art

[0002] Coagulation function refers to the ability of blood to change from a flowing state to a non-flowing gel state. In the process of medical diagnosis and treatment, accurate assessment of coagulation function is crucial for preventing bleeding, thrombosis and other coagulation-related diseases. Traditional coagulation function testing usually relies on large medical equipment and requires professional operators, which limits its application in POCT (point-of-care testing) and Bedside Testing.

[0003] Among the related technologies, microfluidic chip technology can precisely manipulate fluids at the microscale to achieve complex biochemical reactions and detection processes. Due to its advantages such as miniaturization, integration and portability, it has received widespread attention in the field of biomedical testing. However, the current microfluidic chip technology still has some problems in coagulation function detection. For example: 1. Factors such as chip design, reagent selection and operation procedures lead to low detection sensitivity and accuracy; 2. Usually only a single coagulation index can be detected, and the multi-parameter detection capability is limited, which cannot fully reflect the patient's coagulation status; 3. The lack of intelligent data processing and analysis functions leads to insufficient intelligence; 4. It is impossible to achieve docking with the existing medical system; 5. The manufacturing cost is relatively high, and the production efficiency needs to be improved.

[0004] Therefore, it is urgent to propose a coagulation function detection system to achieve a rapid, accurate and comprehensive evaluation of coagulation function. Summary of the invention

[0005] In order to provide a basic understanding of some aspects of the disclosed embodiments, a brief summary is given below. The summary is not an extensive review, nor is it intended to identify key / critical components or delineate the scope of protection of these embodiments, but rather serves as a prelude to the detailed description that follows.

[0006] In view of the above-mentioned shortcomings of the prior art, the present invention discloses a coagulation function detection system, method and storage medium, which are used to solve the technical problem that the coagulation function detection effect in the prior art is not ideal.

[0007] In the first aspect, the present application provides a coagulation function detection system, the system comprising a microfluidic module, a multimodal data detection module and a data processing module that are communicatively connected; the microfluidic module is used to control the flow of blood samples and the coagulation cascade reaction to simulate the coagulation process; the multimodal data detection module comprises an optical detection submodule and an electrochemical detection submodule, the optical detection submodule is used to monitor the fibrinogen concentration change signal during the coagulation process, and the electrochemical detection submodule is used to monitor the prothrombin activity change signal during the coagulation process; the data processing module is used to input the fibrinogen concentration change signal and the prothrombin activity change signal into a coagulation function detection model to obtain a coagulation function state, wherein the coagulation function state includes normal coagulation function, hypercoagulation function and coagulation function disorder.

[0008] In one embodiment of the present invention, the microfluidic module includes a collection unit, a control unit and a microfluidic chip, wherein a micropump, a plurality of microvalves, a microchannel network and a plurality of reaction chambers are integrated on the microfluidic chip; the collection unit is used to collect real-time fluid data, wherein the fluid data includes fluid viscosity, fluid velocity, fluid flow rate and fluid pressure; the control unit is used to determine the driving frequency of the micropump and control the micropump according to the fluid data and preset flow conditions, and to determine the switching timing, switching time and opening of the plurality of microvalves and control the plurality of microvalves, wherein the flow conditions include the target flow rate, target flow rate and target fluid pressure of the blood sample; the micropump is used to drive the blood sample to be transported along the microchannel network at the driving frequency; the plurality of microvalves are used to control the flow direction of the blood sample and the distribution in the plurality of reaction chambers according to the switching timing, switching time and opening.

[0009] In one embodiment of the present invention, a micro-mixer is provided in the reaction chamber; the control unit is further used to control the rotation of the micro-mixer according to a preset rotation speed so that the blood sample in the reaction chamber is mixed with reactants, wherein the reactants include at least an activator and an anticoagulant.

[0010] In one embodiment of the present invention, a temperature sensor and a heating element are also provided in the reaction chamber; the temperature sensor is used to collect the real-time temperature in the reaction chamber and transmit the real-time temperature to the control unit; the control unit is also used to calculate the difference between the real-time temperature and a preset temperature threshold, and determine the real-time heating power of the heating element according to the difference and a preset mapping relationship, and control the heating element to generate heat according to the real-time heating power, wherein the mapping relationship is a corresponding relationship between the difference and the change value.

[0011] In one embodiment of the present invention, the blood sample is treated with a fibrinogen-specific antibody labeled with a fluorescent substance, and the optical detection submodule includes: a laser unit for emitting a laser beam; a filter unit for filtering the laser beam according to an absorption spectrum corresponding to the fluorescent substance, and irradiating the filtered laser beam into the blood sample, as well as the fluorescence and scattered light generated by the fluorescent substance; a photoelectric detection unit for capturing the filtered laser intensity signal, the fluorescence intensity change signal and the scattered light intensity change signal, and determining the absorbance change signal of the blood sample according to the laser intensity signal, the fluorescence intensity change signal and the scattered light intensity change signal, and converting the fluorescence intensity change signal, the scattered light intensity change signal and the absorbance change signal into a fluorescence electrical signal curve, a scattered photoelectric signal curve and an absorbance electrical signal curve, respectively; a concentration analysis unit for matching the fluorescence electrical signal curve, the scattered photoelectric signal curve and the absorbance electrical signal curve with a first standard curve to obtain the fibrinogen concentration change signal, wherein the first standard curve is constructed according to the fluorescence electrical signal, the scattered photoelectric signal and the absorbance electrical signal corresponding to different fibrinogen concentrations.

[0012] In one embodiment of the present invention, the electrochemical detection submodule includes: a current detection unit, used to monitor the current change signal of the blood sample in the coagulation cascade reaction to obtain a current change curve; an activity analysis unit, used to match the current change curve with a second standard curve to obtain the prothrombin activity change signal, wherein the second standard curve is constructed based on the current signals corresponding to different prothrombin activities.

[0013] In one embodiment of the present invention, the data processing module includes: a preprocessing unit, used to preprocess the fibrinogen concentration change signal and the prothrombin activity change signal, wherein the preprocessing includes at least one of denoising, filtering and standardization; a coagulation feature extraction unit, used to perform trend and slope analysis on the preprocessed fibrinogen concentration change signal and the prothrombin activity change signal to obtain the coagulation time, coagulation rate and coagulation factor activity; a coagulation function prediction unit, used to input the coagulation time, the coagulation rate and the coagulation factor activity into the coagulation function detection model to obtain the coagulation function state, wherein the coagulation function detection model is trained and constructed based on a coagulation data set labeled with different coagulation function states.

[0014] In one embodiment of the present invention, the system also includes: a display module for displaying coagulation detection data, the coagulation detection data including the fibrinogen concentration change signal, the prothrombin activity change signal, the coagulation time, the coagulation rate, the coagulation factor activity and the coagulation function, wherein the coagulation time includes the prothrombin time, the activated partial thromboplastin time and the thrombin time; a remote access module for sending the coagulation detection data to the client in response to a data viewing instruction sent by the client; a data sharing module for providing a data interface so that an external system can call the data interface to obtain the coagulation detection data.

[0015] In a second aspect, the present application provides a method for detecting coagulation function, the method comprising: injecting a blood sample into a microfluidic chip, controlling the flow of the blood sample and the coagulation cascade reaction, and simulating the coagulation process, wherein the blood sample is treated with a fibrinogen-specific antibody labeled with a fluorescent substance; emitting a laser beam into the blood sample, and monitoring the fluorescence electrical signal curve, the scattered photoelectric signal curve, and the absorbance electrical signal curve of the blood sample during the coagulation process; using an ion selective electrode and a conductivity sensor to monitor the current change curve of the blood sample during the coagulation process; matching the fluorescence electrical signal curve, the scattered photoelectric signal curve, and the absorbance electrical signal curve with a first standard curve to obtain a fibrinogen concentration change signal. , and matching the current change curve with a second standard curve to obtain a prothrombin activity change signal, wherein the first standard curve is constructed according to the fluorescent electrical signal, scattered photoelectric signal and absorbance electrical signal corresponding to different fibrinogen concentrations, and the second standard curve is constructed according to the current signal corresponding to different prothrombin activities; performing trend and slope analysis on the fibrinogen concentration change signal and the prothrombin activity change signal to obtain the coagulation time, coagulation rate and coagulation factor activity; inputting the coagulation time, the coagulation rate and the coagulation factor activity into a coagulation function detection model to obtain the coagulation function state, wherein the coagulation function detection model is trained and constructed based on a coagulation data set labeled with different coagulation function states.

[0016] In a third aspect, the present application provides a computer-readable storage medium having computer-readable instructions stored thereon. When the computer-readable instructions are executed by a processor of a computer, the computer executes the coagulation function detection method as described in the second aspect.

[0017] As described above, the coagulation function detection system, method and storage medium provided by the embodiments of the present invention have the following beneficial effects:

[0018] The invention relates to a microfluidic module, a multimodal data detection module and a data processing module with integrated communication connections. The microfluidic module is used to control the flow of blood samples and the coagulation cascade reaction to simulate the coagulation process. The multimodal data detection module includes an optical detection submodule and an electrochemical detection submodule. The optical detection submodule is used to monitor the fibrinogen concentration change signal during the coagulation process, and the electrochemical detection submodule is used to monitor the prothrombin activity change signal during the coagulation process. The data processing module is used to input the fibrinogen concentration change signal and the prothrombin activity change signal into the coagulation function detection model to obtain the coagulation function status, including normal coagulation function, hypercoagulation function and coagulation function disorder. The system combines microfluidic chip technology, multimodal detection technology and intelligent algorithm technology to form an intelligent panoramic instant analysis system for coagulation function, which avoids the problems of complex coagulation function detection operation and single coagulation parameter detection, realizes rapid, accurate and comprehensive evaluation of coagulation function, and can meet the instant detection needs in different medical scenarios.

[0019] It should be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present application. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] The drawings herein are incorporated into the specification and constitute a part of the specification, showing embodiments consistent with the present application, and together with the specification, are used to explain the principles of the present application. Obviously, the drawings described below are only some embodiments of the present application, and for those of ordinary skill in the art, other drawings can be obtained based on these drawings without creative work. In the drawings:

[0021] Figure 1 is a schematic diagram of an implementation environment of a coagulation function detection system shown in an exemplary embodiment of the present application;

[0022] Figure 2 is a block diagram of a blood coagulation function detection system shown in an exemplary embodiment of the present application;

[0023] Figure 3 is a block diagram of a specific blood coagulation function detection system shown in an exemplary embodiment of the present application;

[0024] Figure 4 is a block diagram of another blood coagulation function detection system shown in an exemplary embodiment of the present application;

[0025] Figure 5 It is a flow chart of a coagulation function detection method shown in an exemplary embodiment of the present application. DETAILED DESCRIPTION

[0026] The following will describe the embodiments of the present invention with reference to the accompanying drawings and preferred embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. The present invention can also be implemented or applied through other different specific embodiments, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present invention. It should be understood that the preferred embodiments are only for illustrating the present invention, not for limiting the scope of protection of the present invention.

[0027] It should be noted that the illustrations provided in the following embodiments are only used to illustrate the basic concept of the present invention in a schematic manner, and thus the illustrations only show components related to the present invention rather than being drawn according to the number, shape and size of components in actual implementation. In actual implementation, the type, quantity and proportion of each component may be changed arbitrarily, and the component layout may also be more complicated.

[0028] In the following description, numerous details are discussed to provide a more thorough explanation of the embodiments of the present invention. However, it is obvious to those skilled in the art that the embodiments of the present invention can be implemented without these specific details. In other embodiments, well-known structures and devices are shown in the form of block diagrams rather than in detail to avoid making the embodiments of the present invention difficult to understand.

[0029] Traditional coagulation function testing relies on large equipment and professionals, which limits its application in point-of-care testing and bedside testing. Although microfluidic chip technology has attracted attention in the field of biomedical testing due to its miniaturization, integration and portability, the inventors of this application have found that the existing coagulation function testing system still faces challenges in coagulation function testing. For example, there are problems such as insufficient sensitivity and accuracy, single detection parameters, insufficient intelligent analysis, poor system compatibility, high detection cost and low detection efficiency. These limitations limit the rapid, accurate and comprehensive evaluation of coagulation function, resulting in poor detection results.

[0030] Therefore, see Figure 1 , Figure 1 FIG. 1 is a schematic diagram of an implementation environment of a coagulation function detection system shown in an exemplary embodiment of the present application. Figure 1As shown, the implementation environment may include a coagulation function detection system 110 and a computer device 120 for coagulation function detection. Among them, the computer device 120 may be at least one of a desktop graphics processing unit (GPU) computer, a GPU computing cluster, a neural network computer, etc. The coagulation function detection system 110 integrates a microfluidic module, a multimodal data detection module and a data processing module connected by communication, and combines microfluidic chip technology, multimodal detection technology and intelligent algorithm technology to form an intelligent panoramic instant analysis system for coagulation function, which avoids the problems of complex coagulation function detection operation and single coagulation parameter detection, realizes rapid, accurate and comprehensive evaluation of coagulation function, and can meet the instant detection needs in different medical scenarios.

[0031] See also Figure 2 , Figure 2 is a block diagram of a coagulation function detection system shown in an exemplary embodiment of the present application. The system can be applied to Figure 1 The implementation environment shown is a system that should be understood to be applicable to other exemplary implementation environments and to be specifically executed by devices in other implementation environments. This embodiment does not limit the implementation environment to which the system is applicable.

[0032] like Figure 2 As shown, in an exemplary embodiment, the coagulation function detection system 200 includes at least a microfluidic module 210, a multimodal data detection module 220 and a data processing module 230 that are communicatively connected, which are described in detail as follows:

[0033] The microfluidic module 210 is used to control the flow of the blood sample and the coagulation cascade reaction to simulate the coagulation process.

[0034] Among them, the coagulation cascade reaction is a multi-step enzymatic cascade process, which leads to the formation of fibrin clots through the sequential activation of a series of coagulation factors. In this process, inactive prothrombin is activated into active thrombin, which then catalyzes the conversion of fibrinogen into fibrin monomers, eventually forming a fibrin polymer network to achieve blood coagulation.

[0035] In this embodiment, the microfluidic module 210 can accurately simulate the blood coagulation process by controlling the flow of blood samples and the coagulation cascade reaction, thereby ensuring the reliability of coagulation function detection. The coagulation function detection is no longer dependent on large equipment, and through portable detection tools, it meets the needs of clinical diagnosis, treatment monitoring, drug development, and telemedicine for real-time evaluation of coagulation function.

[0036] The multimodal data detection module 220 includes an optical detection submodule and an electrochemical detection submodule. The optical detection submodule is used to monitor the fibrinogen concentration change signal during the coagulation process, and the electrochemical detection submodule is used to monitor the prothrombin activity change signal during the coagulation process.

[0037] In this example, see Figure 3 , Figure 3 FIG. 1 is a block diagram of a specific blood coagulation function detection system shown in an exemplary embodiment of the present application. Figure 3 As shown, the multimodal data detection module 220 includes an optical detection submodule 221 and an electrochemical detection submodule 222, which combine optical detection and electrochemical detection to obtain the fibrinogen concentration change signal and the prothrombin activity change signal during the coagulation process, thereby realizing multi-dimensional coagulation parameter detection to ensure the accuracy and comprehensiveness of coagulation function evaluation.

[0038] The data processing module 230 is used to input the fibrinogen concentration change signal and the prothrombin activity change signal into the coagulation function detection model to obtain the coagulation function status, wherein the coagulation function status includes normal coagulation function, hypercoagulation function and coagulation function disorder.

[0039] In this embodiment, the coagulation function is analyzed by combining the fibrinogen concentration change signals and prothrombin activity change signals of different dimensions. The reliability of coagulation function detection can be enhanced based on multiple coagulation data. In addition, the coagulation function detection model is used to perform coagulation function analysis based on big data, which not only realizes the intelligent evaluation of coagulation function, but also enhances the accuracy of coagulation function detection results.

[0040] In one embodiment, please continue to refer to Figure 3 The microfluidic module 210 includes a collection unit 211, a control unit 212 and a microfluidic chip 213, on which a micropump, a plurality of microvalves, a microchannel network and a plurality of reaction chambers are integrated; the collection unit 211 is used to collect real-time fluid data, and the fluid data includes fluid viscosity, fluid velocity, fluid flow rate and fluid pressure; the control unit 212 is used to determine the driving frequency of the micropump and control the micropump according to the fluid data and the preset flow conditions, and to determine the switching timing, switching time and opening of a plurality of microvalves and control the plurality of microvalves, wherein the flow conditions include the target flow rate, target flow rate and target fluid pressure of the blood sample; the micropump is used to drive the blood sample to be transported along the microchannel network at the driving frequency; the plurality of microvalves are used to control the flow direction of the blood sample and the distribution in the plurality of reaction chambers according to the switching timing, switching time and opening.

[0041] In this embodiment, a micro pump, a plurality of micro valves, a micro channel network and a plurality of reaction chambers are integrated on the microfluidic chip 213. Among them, the micro pump simulates the blood pumping function of the heart, and the micro pump integrated on the microfluidic chip 213 can realize the active delivery of liquid by means of piezoelectric, pneumatic, thermal drive and the like; the micro valve is set at a key position of the micro channel network to control the flow direction and flow rate of the fluid, and can realize the switch function by means of mechanical, electromagnetic, thermal and the like; the micro channel network is designed according to the structural characteristics of the human vascular network, simulating arteries, veins and capillaries of different diameters to reflect the flow characteristics of blood in different blood vessels; the reaction chamber is designed to simulate the process of material exchange between tissue cells and blood, such as the absorption of oxygen and nutrients, the release of carbon dioxide and other metabolic wastes, and is the place to realize the coagulation cascade reaction.

[0042] It should be noted that in the microfluidic chip 213, the human blood flow simulation control process is as follows: first, fluid is injected, and a blood sample is injected into the inlet end of the microfluidic chip 213; then the micropump and microvalve are started, and the micropump simulates the pumping process of the heart, and the fluid is transported along the microchannel network. By adjusting the driving frequency of the micropump, the flow rate and flow rate of the fluid are controlled, and the blood flow under different physiological states can be simulated. The microvalve regulates the flow direction and distribution of the fluid, simulates the branching and confluence in the vascular network, and can achieve complex blood flow patterns by accurately controlling the switching time, switching sequence and opening of the microvalve; then the blood sample flows into the reaction chamber, and the substance exchange process between tissue cells and blood is simulated in the reaction chamber. By setting specific biological molecules or cell layers in the reaction chamber, the biochemical reactions occurring when the blood flows through can be observed and analyzed. The microfluidic chip 213 highly integrates the key components (microchannel network, reaction chamber, micropump, microvalve) required for blood flow simulation on a small chip, realizing a fully automated process from fluid injection to data acquisition. The highly integrated design significantly improves the compactness and portability of the system.

[0043] In this embodiment, real-time fluid data is collected by the collection unit 211, so that real-time monitoring of the flow condition of the blood sample is achieved, so that the control unit 212 can determine the driving frequency of the micropump according to the fluid data and the preset flow conditions to accurately control the micropump, and determine the switching timing, switching time and opening of multiple microvalves to accurately control the multiple microvalves. In this way, the micropump drives the blood sample to be transported along the microchannel network, and the microvalve controls the flow direction of the blood sample and its distribution in multiple reaction chambers, thereby accurately realizing the simulation of the coagulation process.

[0044] In this embodiment, the control unit 212 determines the driving frequency of the micropump and the switching timing, switching time and opening of multiple microvalves based on the fluid data and preset flow conditions. Specifically, the fluid data and flow conditions are input into the working parameter prediction model of the micropump and the microvalves to obtain the driving frequency of the micropump and the switching timing, switching time and opening of the multiple microvalves. The working parameter prediction model is trained based on a data set with marked driving frequency, switching timing, switching time and opening, and the data set includes a large amount of fluid data and flow condition data. In this way, artificial intelligence technology is introduced, and the working status of the micropump and microvalves is predicted and optimized by training the machine learning model, thereby achieving a higher level of automation and intelligent control, which not only improves the accuracy of control, but also reduces the need for manual intervention. In addition, the control unit 212 predicts and regulates the working status of the micropump and microvalve in real time, thereby realizing dynamic flow regulation of the blood sample. Compared with the traditional microfluidic system that relies on preset flow parameters, it can ensure that the flow of the fluid in the chip is always in the best state, and introduce the control of the switching timing of the microvalve, etc., to create specific fluid flow patterns, such as pulse flow, alternating flow, etc., to achieve complex fluid paths and mixing effects.

[0045] In a possible embodiment, the microfluidic chip 213 uses a material with excellent biocompatibility as a substrate, such as PDMS (polydimethylsiloxane), glass or a specific polymer, to ensure the compatibility of the chip with the blood sample and reduce nonspecific adsorption. Taking PDMS as an example, the preparation process of the microfluidic chip 213 includes: first, designing the layout pattern of the microchannel network and the reaction chamber to ensure the precise control and efficient mixing of the fluid in the chip. After the design is completed, the pattern is transferred to the silicon wafer to form a mold to form a mold for making the PDMS chip; then, the PDMS prepolymer and the curing agent are evenly mixed in a certain proportion, the mixed PDMS is poured on the mold, and cured in a constant temperature environment. During the curing process, the temperature and time are accurately controlled to obtain a high-quality PDMS chip; after the curing is completed, the PDMS is peeled off from the mold to obtain a chip with a precise microchannel network and reaction chamber structure. At this time, the chip surface may still need to be further modified to simulate the coagulation environment in the body; finally, the chip surface is modified by coating an anticoagulant. The modification process needs to ensure that the anticoagulant is evenly covered on the chip surface and does not affect the functions of the microchannels and reaction chambers to simulate the coagulation environment in the body; after the modification is completed, the chip is carefully inspected to ensure that there are no flaws and defects, thereby completing the preparation of the microfluidic chip 213.

[0046] As a possible embodiment, through the above-mentioned preparation process, a microfluidic chip 213 with precise structure and stable performance can be obtained, which provides a reliable basis for subsequent coagulation function detection. At the same time, the preparation process is repeatable and scalable, and is suitable for the needs of large-scale production of microfluidic chips 213.

[0047] In a possible embodiment, the microcontroller module structure includes: a core processing structure, which is composed of a high-performance CPU (Central Processing Unit). The CPU receives instructions from external devices, controls the switches of micropumps and microvalves, and processes data from sensors, such as the flow rate and pressure of the fluid, so as to monitor and regulate the blood flow simulation process in real time. The CPU contains an ALU (arithmetic logic unit), a register group, and a control unit, etc., to achieve high-speed calculation and precise control; a memory structure, including ROM (read-only memory), RAM (random access memory), Flash (memory device) and other memories. ROM is used to store fixed programs and data, RAM is used to temporarily store data during operation, and Flash memory combines the characteristics of ROM and RAM, which can not only store data for a long time, but also be erased and reprogrammed; a peripheral interface structure, including ADC (analog-to-digital converter), D AC (digital-to-analog converter), UART (universal asynchronous receiver / transmitter), SPI (serial peripheral interface), etc., are used for communication and data exchange with sensors related to fluid manipulation (such as flow rate sensors, pressure sensors), actuators (such as micropumps, microvalve drive circuits), and equipment for data recording, display or remote communication, so as to simulate and control human blood flow; clock and power management structure, the clock module provides a stable clock signal for the chip to ensure that each module can work synchronously, and the power management module is responsible for monitoring and managing the power supply of the chip, including battery charging, voltage regulation, power consumption control and other functions, so as to extend the overall battery life of the device; security structure, including encryption engine, secure storage area, etc., is used to protect the data and programs inside the chip from unauthorized access and tampering.

[0048] In a possible embodiment, the microchannel network and reaction chamber are manufactured using technologies such as photolithography, soft lithography, and laser processing. The microchannel and reaction chamber structure are etched on a substrate, photoresist is coated on the substrate using photolithography technology, and then exposed and developed through a mask to form a microchannel pattern. PDMS and other materials are used for molding to obtain a chip layer with a microchannel structure.

[0049] As a possible embodiment, the size of the microchannel network is optimized to ensure the laminar flow state of the fluid in the chip and achieve efficient mixing. Specifically, the width and depth of the microchannel are both at the micron level. This size design allows the fluid to form a stable laminar flow when flowing in the microchannel, reducing turbulence and mixing, thereby providing a more precise and controllable fluid dynamics environment. The microchannel can adopt different shapes such as straight, curved or branched to adapt to different fluid dynamics requirements and mixing effect requirements. In addition, obstacles, grooves and other structures are provided in the microchannel to enhance the mixing and mass transfer effects of the fluid. The size, shape and spacing of the obstacles, the depth and width of the grooves, etc., can all be optimized according to specific needs.

[0050] In addition, the microchannel and reaction chamber structure are adjustable. For example, for the microchannel, the width of the microchannel is set between 10-50 microns; the depth of the microchannel is set between 5-30 microns; the length is designed according to the reaction chamber layout and the overall chip size, between several hundred microns and several millimeters; the shape can be designed according to the different stages of the coagulation reaction. A microchannel structure combining a curved type and a branched type. For obstacles in the microchannel, a cylindrical obstacle with a diameter of 5 microns can be set every 200 microns in the microchannel; for grooves in the microchannel, a groove structure with a depth of 1 micron and a width of 5 microns can be designed in a specific area; for the reaction chamber layout, it can be cylindrical, square or elliptical with a diameter of 100 microns and a height of 50 microns. It should be noted that the embodiments of the present application do not limit the data.

[0051] In a possible embodiment, a micro pump can be driven by a pressure sound wave. By adjusting the frequency and amplitude of the sound wave, the output flow rate and pressure of the pump can be accurately controlled. This has the advantage of being non-invasive. By adjusting the frequency (20-50kHz) and amplitude (0-10Vpp) of the sound wave, the output flow rate can be automatically adjusted according to the fluid resistance. A light-controlled micro valve can be used. By accurately controlling the intensity and irradiation position of the light, the opening and closing of the valve can be controlled non-contactly and quickly, which improves the response speed and reduces the complexity of the system. The response time of the micro valve is less than 1 millisecond, and the sealing performance reaches 10^-6Pa·m 3 / s leakage rate ensures precise control of the fluid path.

[0052] As a possible embodiment, the control unit 212 can also adjust the amplitude of the micro pump and the light intensity of the micro valve in real time.

[0053] In one embodiment, a micro mixer is provided in the reaction chamber; the control unit 212 is further used to control the rotation of the micro mixer according to a preset rotation speed so as to mix the blood sample in the reaction chamber with the reactants, wherein the reactants include at least an activator and an anticoagulant.

[0054] In this embodiment, the activator is, for example, phospholipid, TF (tissue factor), CaCl (calcium chloride), etc., and the anticoagulant is, for example, heparin. This embodiment does not limit the types of the activator and the anticoagulant.

[0055] In this embodiment, the micromixer can be a miniature magnetic stirrer with an adjustable speed range of 100-500 rpm. The rotation of the stirrer is controlled by an external magnetic field. In coagulation function testing, it helps to ensure the uniform distribution of coagulation factors, activators and other reactants in the blood, thereby improving the efficiency and accuracy of the coagulation reaction.

[0056] In one embodiment, a temperature sensor and a heating element are also provided in the reaction chamber; the temperature sensor is used to collect the real-time temperature in the reaction chamber and transmit the real-time temperature to the control unit; the control unit 121 is also used to calculate the difference between the real-time temperature and a preset temperature threshold, and determine the real-time heating power of the heating element according to the difference and a preset mapping relationship, and control the heating element to generate heat according to the real-time heating power, wherein the mapping relationship is a corresponding relationship between the difference and the change value.

[0057] In this embodiment, a high-precision temperature sensor and a heating element are integrated in the reaction chamber, and the reaction temperature is accurately controlled within the range of 37°C ± 0.1°C by the control unit 121 to simulate the coagulation reaction conditions under normal human body temperature. Preferably, the temperature sensor and the heating element are integrated at the bottom of the reaction chamber, so that the temperature distribution in the reaction chamber is uniform.

[0058] In the embodiments of the present application, multiple microchannel layers and reaction chamber layers are integrated into a single chip through three-dimensional stacking technology to achieve a miniaturized design of the overall size, which is convenient for handheld operation and portable application; the adjustable microchannel width and depth structure is designed, and the user can fine-tune it through software control according to specific experimental needs. At the same time, a standardized interface and modular design are provided to support seamless integration and expansion with other microfluidic components, including but not limited to fluid delivery equipment, optical detection equipment, electrochemical detection equipment, data processing and analysis equipment, medical information systems, and remote monitoring equipment (such as smart phones, tablets, etc.).

[0059] In one embodiment, please continue to refer to Figure 3, the blood sample is treated with a fibrinogen-specific antibody labeled with a fluorescent substance, and the optical detection submodule 221 includes: a laser unit for emitting a laser beam; a filter unit for filtering the laser beam according to the absorption spectrum corresponding to the fluorescent substance, and irradiating the filtered laser beam into the blood sample, as well as the fluorescence and scattered light generated by the fluorescent substance; a photoelectric detection unit for capturing the filtered laser intensity signal, the fluorescence intensity change signal and the scattered light intensity change signal, and determining the absorbance change signal of the blood sample according to the laser intensity signal, the fluorescence intensity change signal and the scattered light intensity change signal, and converting the fluorescence intensity change signal, the scattered light intensity change signal and the absorbance change signal into a fluorescence electrical signal curve, a scattered photoelectric signal curve and an absorbance electrical signal curve respectively; a concentration analysis unit for matching the fluorescence electrical signal curve, the scattered photoelectric signal curve and the absorbance electrical signal curve with the first standard curve to obtain a fibrinogen concentration change signal, wherein the first standard curve is constructed according to the fluorescence electrical signal, the scattered photoelectric signal and the absorbance electrical signal corresponding to different fibrinogen concentrations.

[0060] In this embodiment, the optical detection submodule 221 integrates a laser unit, a filter unit, a photoelectric detection unit and a concentration analysis unit, and automatically realizes the detection of the fibrinogen concentration change signal during the coagulation process. In addition, the fibrinogen concentration change signal is obtained by comprehensive analysis of the fluorescence intensity change signal, the scattered light intensity change signal and the absorbance change signal. In this way, through the laser unit, the filter unit and the photoelectric detection unit, high-sensitivity and high-resolution optical signal collection can be ensured, and the combined application of fluorescence spectroscopy, absorption spectroscopy and scattering spectroscopy technology can enhance the accuracy of fibrinogen concentration change signal detection.

[0061] In this embodiment, the laser unit, the filter unit, and the photoelectric detection unit work together. The laser unit emits stable, high-intensity excitation light, which has a specific wavelength and is intended to excite fluorescent substances in the blood sample; the filter unit filters the excitation light to ensure that only light of a specific wavelength can be irradiated on the blood sample, while blocking light of other wavelengths from entering to reduce background noise; after the blood sample is excited, it will emit fluorescence, generate absorbed light and scattered light, and the filter unit will work again to selectively transmit fluorescent signals or absorbed light and scattered light of a specific wavelength, while blocking other unnecessary light signals; the photoelectric detection unit receives and measures these filtered light signals and converts them into electrical signals. As the coagulation reaction proceeds, the concentration of fibrinogen will change, thereby obtaining accurate fluorescence electrical signal curves, scattered photoelectric signal curves, and absorbance electrical signal curves, that is, curves of fluorescence intensity, scattered light intensity, and absorbance changing with time.

[0062] In one embodiment, please continue to refer to Figure 3The electrochemical detection submodule 222 includes: a current detection unit, which is used to monitor the current change signal of the blood sample in the coagulation cascade reaction and obtain a current change curve; an activity analysis unit, which is used to match the current change curve with the second standard curve to obtain a prothrombin activity change signal, wherein the second standard curve is constructed according to the current signals corresponding to different prothrombin activities.

[0063] In this embodiment, the activity change data of prothrombin is obtained by current measurement. Prothrombin is a key enzyme in the coagulation process, and its activity directly affects the speed of the coagulation reaction. In electrochemical detection, specific electrodes and electrolytes are used to monitor the current changes generated when prothrombin reacts with substrates. The change in current is proportional to the activity of prothrombin, so it can be used to evaluate the activity change of prothrombin.

[0064] In this embodiment, the current detection unit captures key events in the coagulation process by measuring the change in current potential, and uses ion-selective electrodes and conductivity sensors to achieve accurate monitoring of electrolyte concentrations and ion (such as chloride ions, sodium ions) activities, thereby obtaining accurate measurement values ​​of electrolyte concentrations and ion activities in the coagulation process. The change in current signal reflects the occurrence of key biochemical events in the coagulation process, namely, the change in prothrombin activity, thereby ensuring the reliability of the obtained prothrombin activity change signal and further ensuring the reliability of the coagulation function.

[0065] In a possible embodiment, in order to verify the accuracy of the multimodal data detection module 220, a known concentration of fibrinogen and a known activity of prothrombin standard are used for testing, and the sensitivity and accuracy of the detection are tested by comparing with the traditional detection method. In addition, the stability, repeatability and anti-interference ability of the multimodal data detection module 220 are tested. The parameters of the multimodal data detection module 220 are adjusted according to the test results to ensure the detection accuracy of the multimodal data detection module 220.

[0066] In one embodiment, please continue to refer to Figure 3 The data processing module 230 includes: a preprocessing unit 231, which is used to preprocess the fibrinogen concentration change signal and the prothrombin activity change signal, wherein the preprocessing includes at least one of denoising, filtering and standardization; a coagulation feature extraction unit 232, which is used to perform trend and slope analysis on the preprocessed fibrinogen concentration change signal and the prothrombin activity change signal to obtain the coagulation time, coagulation rate and coagulation factor activity; a coagulation function prediction unit 233, which is used to input the coagulation time, coagulation rate and coagulation factor activity into a coagulation function detection model to obtain the coagulation function state, wherein the coagulation function detection model is trained and constructed based on a coagulation data set labeled with different coagulation function states.

[0067] In this embodiment, the preprocessing unit 231 applies denoising, filtering and standardization algorithms to process the fibrinogen concentration change signal and the prothrombin activity change signal, thereby improving the data quality. These algorithms can eliminate noise interference, smooth data fluctuations, and standardize the data to the same scale to facilitate subsequent feature extraction and coagulation function prediction.

[0068] In this embodiment, the coagulation feature extraction unit 232 performs trend and slope analysis on the pretreated fibrinogen concentration change signal and the prothrombin activity change signal to obtain the coagulation time and coagulation rate. A machine learning algorithm can be used to extract key coagulation features such as coagulation time, coagulation rate and coagulation factor activity from the pretreated data to ensure the accuracy of the obtained coagulation time, coagulation rate and coagulation factor activity.

[0069] In this embodiment, the coagulation function prediction unit 23 inputs the coagulation time, coagulation rate and coagulation factor activity into the coagulation function detection model to obtain the coagulation function state. The coagulation function detection model is trained and constructed based on a coagulation data set that annotates different coagulation function states, wherein the coagulation data set includes a large amount of coagulation time, coagulation rate and coagulation factor activity data. In this way, intelligent detection of coagulation function is realized, and the reliability of the obtained coagulation function state can be ensured.

[0070] In a possible embodiment, the coagulation function detection model is continuously optimized, and new sample data is regularly used to train and verify the model to improve its generalization ability and accuracy.

[0071] The model uses advanced machine learning algorithms, such as support vector machines (SVMs), random forests, or deep learning networks, to identify and classify the coagulation status of samples. Through training and optimization, the model can accurately identify different states such as normal coagulation, hypercoagulation, and coagulation disorders. In order to verify the accuracy of the model, samples with known coagulation status were used for testing. These samples were derived from clinical practice, had different coagulation status, and were accurately diagnosed by clinicians. The model was optimized by comparing the recognition results of the model with the diagnosis results of the doctors.

[0072] In one embodiment, see Figure 4 , Figure 4 FIG. 1 is a block diagram of another blood coagulation function detection system shown in an exemplary embodiment of the present application. Figure 4As shown, the coagulation function detection system 200 also includes: a display module 240, which is used to display coagulation detection data, and the coagulation detection data includes a fibrinogen concentration change signal, a prothrombin activity change signal, a coagulation time, a coagulation rate, a coagulation factor activity and a coagulation function, wherein the coagulation time includes a prothrombin time, an activated partial thromboplastin time and a thrombin time; a remote access module 250, which is used to send the coagulation detection data to the client in response to a data viewing instruction sent by the client; a data sharing module 260, which is used to provide a data interface so that an external system can call the data interface to obtain the coagulation detection data.

[0073] In this embodiment, the display module 240 can intuitively display the coagulation test data through the display screen, which is convenient for intuitive understanding when the coagulation function test is performed on site.

[0074] In this embodiment, the remote access module 250 can send the coagulation test data to the client through wireless communication technology to realize remote viewing and analysis functions, provide users with a convenient means of monitoring the coagulation status, so that users can fully understand their own coagulation function status, or doctors can remotely access the patient's coagulation test data to formulate a suitable treatment plan for the patient.

[0075] In this embodiment, the data sharing module 260 realizes the sharing of coagulation detection data, so that the external system calls the data interface to obtain the coagulation detection data, for example, seamlessly connects with existing medical equipment and information systems to realize data sharing and efficient utilization.

[0076] It should be noted that the coagulation time including prothrombin time, activated partial thromboplastin time and thrombin time can all be obtained by analyzing the prothrombin activity change signal.

[0077] In a possible embodiment, in the coagulation function test, the D-dimer concentration can also be detected. The detection of D-dimer is usually not directly through multimodal optical or electrochemical methods, but through other biochemical methods such as immunoturbidimetry. In the multimodal data detection module 220, it can be detected and calculated by a method similar to the fibrinogen concentration change signal.

[0078] The above-mentioned coagulation function detection system integrates a microfluidic module, a multimodal data detection module and a data processing module with communication connections. The microfluidic module is used to control the flow of blood samples and the coagulation cascade reaction to simulate the coagulation process. The multimodal data detection module includes an optical detection submodule and an electrochemical detection submodule, wherein the optical detection submodule is used to monitor the fibrinogen concentration change signal during the coagulation process, and the electrochemical detection submodule is used to monitor the prothrombin activity change signal during the coagulation process. The data processing module is used to input the fibrinogen concentration change signal and the prothrombin activity change signal into the coagulation function detection model to obtain the coagulation function status, including normal coagulation function, hypercoagulation function and coagulation function disorder. The system combines microfluidic chip technology, multimodal detection technology and intelligent algorithm technology to form an intelligent panoramic instant analysis system for coagulation function, which avoids the problems of complex coagulation function detection operation and single coagulation parameter detection, realizes rapid, accurate and comprehensive evaluation of coagulation function, and can meet the instant detection needs in different medical scenarios.

[0079] More specifically, the system provides strong support for clinical diagnosis and treatment, and is applicable to clinical diagnosis and treatment monitoring, emergency medicine, personalized medicine and precision treatment, drug research and development, telemedicine and health management, etc. Specifically, the effects are reflected in the following aspects:

[0080] 1. Improved evaluation accuracy: By integrating microfluidics technology and multimodal detection methods, it is possible to simultaneously capture multiple signal changes in the coagulation process, thereby more comprehensively reflecting the coagulation state. Compared with traditional single detection methods, the evaluation accuracy is significantly improved;

[0081] 2. Shorten the detection time: Since the microfluidic chip has excellent fluid manipulation capabilities, it can complete the precise manipulation and reaction of samples in a short time. At the same time, the application of intelligent data analysis algorithms also greatly shortens the data processing time. Therefore, it can provide the evaluation results of coagulation function in a very short time, meeting the clinical demand for rapid detection;

[0082] 3. Reduce detection costs: Microfluidic chips are made of biocompatible materials and have the advantages of low cost and mass production. In addition, since the system realizes automated detection and data processing, it reduces the need for manual operation and professionals, further reducing detection costs;

[0083] 4. Improve user experience. Through intuitive result display, users can easily obtain the evaluation results of coagulation function. At the same time, the remote viewing and analysis function enables users to obtain their coagulation status information anytime and anywhere, which greatly improves the user experience;

[0084] 5. Promote data sharing and integration: Provide standardized data interfaces that can exchange and share data with external systems such as medical information systems, help integrate and share coagulation function information, and promote the development of medical informatization.

[0085] See also Figure 5 , Figure 5 is a flow chart of a coagulation function detection method shown in an exemplary embodiment of the present application. The method can be applied to Figure 1 The implementation environment shown is shown. It should be understood that the method can also be applied to other exemplary implementation environments, and this embodiment does not limit the implementation environment to which the method is applicable.

[0086] like Figure 5 As shown, in an exemplary embodiment, the coagulation function detection method includes at least steps S510 to S560, which are described in detail as follows:

[0087] Step S510, injecting a blood sample into a microfluidic chip, controlling the flow of the blood sample and the coagulation cascade reaction, simulating the coagulation process, wherein the blood sample is treated with a fibrinogen-specific antibody labeled with a fluorescent substance;

[0088] Step S520, emitting a laser beam into the blood sample, and monitoring the fluorescence electrical signal curve, the scattered photoelectric signal curve, and the absorbance electrical signal curve of the blood sample during the coagulation process;

[0089] Step S530, using an ion selective electrode and a conductivity sensor to monitor a current change curve of the blood sample during the coagulation process;

[0090] Step S540, matching the fluorescence electric signal curve, the scattered photoelectric signal curve, and the absorbance electric signal curve with the first standard curve to obtain a fibrinogen concentration change signal, and matching the current change curve with the second standard curve to obtain a prothrombin activity change signal, wherein the first standard curve is constructed according to the fluorescence electric signal, the scattered photoelectric signal, and the absorbance electric signal corresponding to different fibrinogen concentrations, and the second standard curve is constructed according to the current signal corresponding to different prothrombin activities;

[0091] Step S550, performing trend and slope analysis on the fibrinogen concentration change signal and the prothrombin activity change signal to obtain the coagulation time, coagulation rate and coagulation factor activity;

[0092] Step S560, inputting the coagulation time, coagulation rate and coagulation factor activity into a coagulation function detection model to obtain the coagulation function state, wherein the coagulation function detection model is trained and constructed based on a coagulation data set annotated with different coagulation function states.

[0093] It should be noted that the coagulation function detection method provided in the above embodiment and the coagulation function detection system provided in the above embodiment belong to the same concept, and the contents of each step have been described in detail in the system embodiment and will not be repeated here.

[0094] The present application also provides a computer-readable storage medium on which a computer program is stored. When the computer program is executed by a processor of a computer, the computer executes the above-mentioned coagulation function health management method. The computer-readable storage medium may be included in an electronic device, or may exist independently without being assembled into the electronic device.

[0095] It should be noted that the computer-readable medium shown in the embodiment of the present application can be a computer-readable signal medium or a computer-readable storage medium or any combination of the above two. The computer-readable storage medium can be, for example, an electrical, magnetic, optical, electromagnetic, infrared, or semiconductor system, device or device, or any combination of the above. More specific examples of computer-readable storage media can include, but are not limited to: an electrical connection with one or more wires, a portable computer disk, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM), a flash memory, an optical fiber, a portable compact disk read-only memory (CD-ROM), an optical storage device, a magnetic storage device, or any suitable combination of the above. In the present application, a computer-readable signal medium may include a data signal propagated in a baseband or as part of a carrier wave, wherein a computer-readable computer program is carried. This propagated data signal can take a variety of forms, including but not limited to an electromagnetic signal, an optical signal, or any suitable combination of the above. The computer-readable signal medium may also be any computer-readable medium other than a computer-readable storage medium, which may send, propagate or transmit a program for use by or in combination with an instruction execution system, device or device. The computer program contained on the computer-readable medium may be transmitted by any appropriate medium, including but not limited to: wireless, wired, etc., or any suitable combination of the above. The flowcharts and block diagrams in the accompanying drawings illustrate the possible implementation architecture, functions and operations of the system, method and computer program product according to various embodiments of the present invention. Among them, each box in the flowchart or block diagram may represent a module, a program segment, or a part of a code, and the above module, program segment, or a part of a code contains one or more executable instructions for implementing a specified logical function. It should also be noted that in some alternative implementations, the functions marked in the box may also occur in an order different from that marked in the accompanying drawings. For example, two boxes represented in succession may actually be executed substantially in parallel, and they may sometimes be executed in the opposite order, depending on the functions involved. It should also be noted that each block in the block diagrams or flowcharts, and combinations of blocks in the block diagrams or flowcharts, can be implemented by a dedicated hardware-based system that performs the specified functions or operations, or can be implemented by a combination of dedicated hardware and computer instructions.

[0096] The units involved in the embodiments of the present invention may be implemented by software or hardware, and the units described may also be arranged in a processor. The names of these units do not, in some cases, limit the units themselves.

[0097] The above embodiments are merely illustrative of the principles and effects of the present invention, and are not intended to limit the present invention. Anyone familiar with the technology may modify or change the above embodiments without violating the spirit and scope of the present invention. Therefore, all equivalent modifications or changes made by a person of ordinary skill in the art without departing from the spirit and technical ideas disclosed by the present invention shall still be covered by the claims of the present invention.

Claims

1. A coagulation function detection system, characterized in that: The system includes a microfluidic module, a multimodal data detection module and a data processing module that are communicatively connected; The microfluidic module is used to control the flow of blood samples and the coagulation cascade reaction to simulate the coagulation process; The multimodal data detection module includes an optical detection submodule and an electrochemical detection submodule, wherein the optical detection submodule is used to monitor the fibrinogen concentration change signal during the coagulation process, and the electrochemical detection submodule is used to monitor the prothrombin activity change signal during the coagulation process; The data processing module is used to input the fibrinogen concentration change signal and the prothrombin activity change signal into a coagulation function detection model to obtain a coagulation function state, wherein the coagulation function state includes normal coagulation function, hypercoagulation function and coagulation function disorder.

2. The blood coagulation function detection system according to claim 1, characterized in that: The microfluidic module includes a collection unit, a control unit and a microfluidic chip, and the microfluidic chip is integrated with a micropump, a plurality of microvalves, a microchannel network and a plurality of reaction chambers; The acquisition unit is used to acquire real-time fluid data, wherein the fluid data includes fluid viscosity, fluid velocity, fluid flow rate and fluid pressure; The control unit is used to determine the driving frequency of the micro pump and control the micro pump according to the fluid data and the preset flow conditions, and determine the switching timing, switching time and opening degree of the plurality of micro valves and control the plurality of micro valves, wherein the flow conditions include the target flow rate, target flow rate and target fluid pressure of the blood sample; The micropump is used to drive the blood sample to be transported along the microchannel network at the driving frequency; The plurality of microvalves are used to control the flow direction of the blood sample and its distribution in the plurality of reaction chambers according to the switch timing, the switch time and the opening degree.

3. The blood coagulation function detection system according to claim 2, characterized in that: A micro mixer is provided in the reaction chamber; The control unit is further used to control the rotation of the micro-mixer according to a preset rotation speed so as to mix the blood sample and reactants in the reaction chamber, wherein the reactants at least include an activator and an anticoagulant.

4. The blood coagulation function detection system according to claim 2, characterized in that: The reaction chamber is also provided with a temperature sensor and a heating element; The temperature sensor is used to collect the real-time temperature in the reaction chamber and transmit the real-time temperature to the control unit; The control unit is also used to calculate the difference between the real-time temperature and a preset temperature threshold, and determine the real-time heating power of the heating element according to the difference and a preset mapping relationship, and control the heating element to generate heat according to the real-time heating power, wherein the mapping relationship is a corresponding relationship between the difference and the change value.

5. The blood coagulation function detection system according to claim 1, characterized in that: The blood sample is treated with a fibrinogen-specific antibody labeled with a fluorescent substance, and the optical detection submodule comprises: A laser unit, used for emitting a laser beam; A filter unit, used for filtering the laser beam according to the absorption spectrum corresponding to the fluorescent substance, and irradiating the filtered laser beam into the blood sample, as well as the fluorescence and scattered light generated by the fluorescent substance; a photoelectric detection unit, used to capture the filtered laser intensity signal, the fluorescence intensity change signal and the scattered light intensity change signal, and determine the absorbance change signal of the blood sample according to the laser intensity signal, the fluorescence intensity change signal and the scattered light intensity change signal, and convert the fluorescence intensity change signal, the scattered light intensity change signal and the absorbance change signal into a fluorescence electrical signal curve, a scattered photoelectric signal curve and an absorbance electrical signal curve, respectively; A concentration analysis unit is used to match the fluorescence electrical signal curve, the scattered photoelectric signal curve, and the absorbance electrical signal curve with a first standard curve to obtain the fibrinogen concentration change signal, wherein the first standard curve is constructed according to the fluorescence electrical signal, scattered photoelectric signal, and absorbance electrical signal corresponding to different fibrinogen concentrations.

6. The blood coagulation function detection system according to claim 1, characterized in that: The electrochemical detection submodule comprises: A current detection unit, used to monitor the current change signal of the blood sample in the coagulation cascade reaction and obtain a current change curve; The activity analysis unit is used to match the current change curve with a second standard curve to obtain the prothrombin activity change signal, wherein the second standard curve is constructed according to the current signals corresponding to different prothrombin activities.

7. The blood coagulation function detection system according to any one of claims 1 to 6, characterized in that: The data processing module comprises: A preprocessing unit, used for preprocessing the fibrinogen concentration change signal and the prothrombin activity change signal, wherein the preprocessing includes at least one of denoising, filtering and standardization; A coagulation feature extraction unit, used for performing trend and slope analysis on the pre-treated fibrinogen concentration change signal and the prothrombin activity change signal to obtain coagulation time, coagulation rate and coagulation factor activity; The coagulation function prediction unit is used to input the coagulation time, the coagulation rate and the coagulation factor activity into the coagulation function detection model to obtain the coagulation function state, wherein the coagulation function detection model is trained and constructed based on a coagulation data set annotated with different coagulation function states.

8. The blood coagulation function detection system according to claim 7, characterized in that: The system further comprises: A display module, used for displaying coagulation detection data, wherein the coagulation detection data includes the fibrinogen concentration change signal, the prothrombin activity change signal, the coagulation time, the coagulation rate, the coagulation factor activity and the coagulation function, wherein the coagulation time includes the prothrombin time, the activated partial thromboplastin time and the thrombin time; A remote access module, configured to send the coagulation test data to the client in response to a data viewing instruction sent by the client; The data sharing module is used to provide a data interface so that an external system can call the data interface to obtain the coagulation detection data.

9. A method for detecting coagulation function, characterized in that: The method comprises: Injecting a blood sample into a microfluidic chip to control the flow of the blood sample and the coagulation cascade reaction to simulate the coagulation process, wherein the blood sample is treated with a fibrinogen-specific antibody labeled with a fluorescent substance; emitting a laser beam into the blood sample to monitor a fluorescence electrical signal curve, a scattered photoelectric signal curve, and an absorbance electrical signal curve of the blood sample during the coagulation process; Using ion selective electrodes and conductivity sensors to monitor the current change curve of the blood sample during the coagulation process; Matching the fluorescence electric signal curve, the scattered photoelectric signal curve, and the absorbance electric signal curve with a first standard curve to obtain a fibrinogen concentration change signal, and matching the current change curve with a second standard curve to obtain a prothrombin activity change signal, wherein the first standard curve is constructed according to the fluorescence electric signal, scattered photoelectric signal, and absorbance electric signal corresponding to different fibrinogen concentrations, and the second standard curve is constructed according to the current signal corresponding to different prothrombin activities; Performing trend and slope analysis on the fibrinogen concentration change signal and the prothrombin activity change signal to obtain coagulation time, coagulation rate and coagulation factor activity; The coagulation time, the coagulation rate and the coagulation factor activity are input into a coagulation function detection model to obtain the coagulation function state, wherein the coagulation function detection model is trained and constructed based on a coagulation data set annotated with different coagulation function states.

10. A computer-readable storage medium, characterized in that: Computer-readable instructions are stored thereon, and when the computer-readable instructions are executed by a processor of a computer, the computer is enabled to execute the blood coagulation function detection method according to claim 9.

Citation Information

Cited By

  • Diagnosis method and detection system based on autoimmune disease antibody detection

    CN119985638A

  • Blood platelet, blood sugar and blood coagulation function joint detection chip, detection device and detection method

    CN121595524A